NVDA
54
5
SYF
74
5
ABBV
59
13
MA
55
4
CMI
71
2
SIG
46
2
V
52
2
EW
58
5
QCOM
45
2
WHR
50
-5
FTI
69
11
AMGN
34
3
MLM
67
4
LOW
43
-6
ADT
50
2
RIG
40
2
VFC
70
2
PGR
42
2
STT
62
3
MCK
67
3
NVDA
54
5
SYF
74
5
ABBV
59
13
MA
55
4
CMI
71
2
SIG
46
2
V
52
2
EW
58
5
QCOM
45
2
WHR
50
-5
FTI
69
11
AMGN
34
3
MLM
67
4
LOW
43
-6
ADT
50
2
RIG
40
2
VFC
70
2
PGR
42
2
STT
62
3
MCK
67
3
Financhill
Back

Rocket Pharmaceuticals, Inc. Vs. Nebius Group NV Industry Stock Comparison

Sell
20

RCKT
Rocket Pharmaceuticals, Inc.

Last Price:
$3.22
Seasonality Move:
4.26%
Sell
42

NBIS
Nebius Group NV

Last Price:
$89.47
Seasonality Move:
-2.57%
Sell
20
Rocket Pharmaceuticals, Inc. (RCKT) is a Sell

Is Rocket Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.23. The Score for RCKT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals, Inc.'s stock price today?

  • The Rocket Pharmaceuticals, Inc. share price today is $3.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing slight selling pressure.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $89.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.61 Buy
Relative Strength Index (14 RSI): 46.7 Sell
Chaikin Money Flow: -281881 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.02 - 3.44) Sell
Bollinger Bands (100): (3.01 - 3.63) Sell

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 47.32 Sell
Chaikin Money Flow: 13904832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.34 - 98.02) Sell
Bollinger Bands (100): (72.32 - 115.66) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.38 Sell
20-day SMA: 3.3 Sell
50-day SMA: 3.44 Sell
200-day SMA: 4.26 Sell
8-day EMA: 1.72 Buy
20-day EMA: 0.84 Buy
50-day EMA: 0.37 Buy
200-day EMA: 0.1 Buy

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.08 Buy
20-day SMA: 91.37 Sell
50-day SMA: 102.98 Sell
200-day SMA: 65.21 Buy
8-day EMA: 85.42 Buy
20-day EMA: 90.53 Sell
50-day EMA: 95.55 Sell
200-day EMA: 73.6 Buy

Rocket Pharmaceuticals, Inc. Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.73 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Rocket Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):